ONO-8539: Clinical Trials

1 trial of ONO-8539, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow ONO-8539: new trials by email Literature Review of ONO-8539 trials Research Report on ONO-8539

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of ONO-8539 in Patients With Overactive Bladder
Placebo, Tolterodine, ONO-8539 - Overactive Bladder
Phase 2CompletedOno Pharmaceutical Co., Ltd.4352009-04-012012-06-14

Conditions studied

Urinary Bladder, Overactive (1)

Sponsors

Ono Pharmaceutical Co., Ltd. (1)

Countries

Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Sweden (1)  ·  Ukraine (1)

Top investigators

Tomohiro Kuwayama (1)